ES2133468T3 - Agentes endoparasitizidas a base de tetradepsipeptidos de cadena abierta. - Google Patents

Agentes endoparasitizidas a base de tetradepsipeptidos de cadena abierta.

Info

Publication number
ES2133468T3
ES2133468T3 ES94118680T ES94118680T ES2133468T3 ES 2133468 T3 ES2133468 T3 ES 2133468T3 ES 94118680 T ES94118680 T ES 94118680T ES 94118680 T ES94118680 T ES 94118680T ES 2133468 T3 ES2133468 T3 ES 2133468T3
Authority
ES
Spain
Prior art keywords
open chain
endoparasitized
agents based
tetradepsipeptides
chain tetradepsipeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94118680T
Other languages
English (en)
Inventor
Jurgen Dr Scherkenbeck
Peter Dr Jeschke
Andrew Dr Plant
Achim Dr Harder
Norbert Dr Mencke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2133468T3 publication Critical patent/ES2133468T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Abstract

LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE TETRADEPSIPEPTIDOS DE CADENA ABIERTA DE LA FORMULA GENERAL (I) ASI COMO SUS ISOMEROS OPTICOS Y RACEMATOS, PARA LA LUCHA CONTRA ENDOPARASITOS EN LA MEDICINA Y EN LA APLICACION VETERINARIA.
ES94118680T 1993-12-09 1994-11-28 Agentes endoparasitizidas a base de tetradepsipeptidos de cadena abierta. Expired - Lifetime ES2133468T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4341992A DE4341992A1 (de) 1993-12-09 1993-12-09 Endoparasitizide Mittel auf Basis von offenkettigen Tetradepsipeptiden

Publications (1)

Publication Number Publication Date
ES2133468T3 true ES2133468T3 (es) 1999-09-16

Family

ID=6504573

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94118680T Expired - Lifetime ES2133468T3 (es) 1993-12-09 1994-11-28 Agentes endoparasitizidas a base de tetradepsipeptidos de cadena abierta.

Country Status (5)

Country Link
US (1) US5571793A (es)
EP (1) EP0657172B1 (es)
JP (1) JP3798825B2 (es)
DE (2) DE4341992A1 (es)
ES (1) ES2133468T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19529604A1 (de) * 1995-08-11 1997-02-13 Bayer Ag Endoparasitizide Mittel auf Basis von Didepsipeptiden, neue Didepsipeptide und ein Verfahren zu ihrer Herstellung
DE19962145A1 (de) * 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel/Depsipeptide
DE19962147A1 (de) * 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
DE10032880A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier IV
US20120302496A1 (en) 2009-12-11 2012-11-29 Bayer Intellectual Property Gmbh Novel 24-membered cyclooctadepsipeptides from fungal strains and their use as anthelmintics or endoparasiticides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung

Also Published As

Publication number Publication date
EP0657172A1 (de) 1995-06-14
JPH07196487A (ja) 1995-08-01
US5571793A (en) 1996-11-05
DE4341992A1 (de) 1995-06-14
DE59408241D1 (de) 1999-06-17
EP0657172B1 (de) 1999-05-12
JP3798825B2 (ja) 2006-07-19

Similar Documents

Publication Publication Date Title
GT199900215A (es) Formulaciones agroquimicas.
ES2076688T3 (es) Derivados de 2-hidroxi-2-feniletilamina utiles como agonistas de beta-3-adrenoceptores.
ES2127859T3 (es) Derivados de la 3-aril-4-hidroxi-3-dihidrofuranona.
GT200200114A (es) Champues con alcohol de behenilo
ES2170460T3 (es) Compuestos triaromaticos, composiciones que los contienen y utilizaciones.
GT200300294A (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
HN2003000408A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos.
CO4340688A1 (es) Derivados de quinazolina y procedimientos de uso de los mismos, como agentes contra el cancer, en los mamiferos.
UY27740A1 (es) Nuevos compuestos
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
ES2184970T3 (es) Utilizacion de derivados de la melatonina para la despigmentacion de la piel y composiciones que las comprenden.
ES2239366T3 (es) Concentrados de brillo nacarado acuosos.
BR0314195A (pt) Derivados de piridina substituìda como agentes antitumorais
HN2002000110A (es) Uso de (z) - 2 - ciano - 3 - hidroxi - butil - 2 - acido enoico (4' - trifluorometil fenilo) - amida para el tratamiento de la esclerosis multiple.
PA8553101A1 (es) Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion
CR7678A (es) Heterociclilpyrimidinos sustituidos
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ES2133468T3 (es) Agentes endoparasitizidas a base de tetradepsipeptidos de cadena abierta.
ES2133467T3 (es) Agente endoparasitizida a base de octadepsipeptidos de cadena abierta.
ES2132309T3 (es) Agentes endoparasiticidas a base de hexadepsipeptidos de cadena abierta.
AR025351A1 (es) Agonistas retinoides selectivos par
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
ES2052484T1 (es) N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 657172

Country of ref document: ES